A client with preexisting bipolar disorder is receiving filgrastim (Neupogen) for the management of neutropenia following chemotherapy treatments for lymphocytic leukemia. The oncology nurse recognizes that which medication for bipolar disorder could complicate the management of the client's leukemia?

Question

Quizplus · Accepted Answer

Lithium carbonate can cause leukocytosis and increase the risk of myeloproliferative disorders, which could exacerbate the client's leukemia. Valproic acid and carbamazepine are not typically associated with significant hematologic side effects. Clonazepam is an anti-anxiety medication and is not typically used as a mood stabilizer in bipolar disorder.

A Client with Preexisting Bipolar Disorder Is Receiving Filgrastim (Neupogen)